Frequency of HIV and HCV co-infections in chronic HBV patients referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010

Hepatitis Monthly

Volumn 11, Issue 12, 2011, Pages 993-996

  Tahaei, Seyed Mohammad Ebrahim ^a   Mohebbi, Seyed Reza ^a   Azimzadeh, Pedram ^a   Vahedi, Mohsen ^a   Almasi, Shohreh ^a   Romani, Sara ^a   Sharifian, Afsaneh ^a   Derakhshan, Faramarz ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Co infection; Epidemiology Frequency; Hepatitis B; Hepatitis C; Human Immunodeficiency Virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG CHOICE; FEMALE; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; VIRUS TRANSMISSION;

EID: 84855801552     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.740     Document Type: Article

References (19)

1. World Health organization. Fact sheets of Hepatitis B. WHo. [updat-ed 2008 August]; Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
2. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang. 1979;37(3):182-6.
3. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6.
4. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int. 2009;29(Suppl 1):1-8.
5. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, et al. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007;10(24):4461-6.
6. Quinn TC. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS. 2008;22(Suppl 3):S7-12.
7. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol. 2008;29(3):136-47.
8. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A. prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009;49(10):2214-20.
9. Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pak J Med Sci. 2007;23(4):510-3.
10. Sharif M, Sherif A, Sayyah M. Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan.Indian J Sex Transm Dis. 2009;30(1):28.
11. Torabi SA, Abedashtiani K, Dehkada R, Moghadam AN, Bahram M, Babaei J, et al. prevalence of hepatitis B, C and HIV in hemophiliac patients of East Azarbaijan in 2004. Blood (Khoon). 2006;2(7):291-9.
12. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology. 1991;14(1):64-7.
13. Mohamed Ael S, al Karawi MA, Mesa GA. Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients. Hepatogastroenterology. 1997;44(17):1404-6.
14. Bodsworth NJ, Cooper DA, Donovan B. The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis. 1991;163(5):1138-40.
15. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis. 2003;23(1):21-38.
16. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008;22(12):1399-410.
17. Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS. 2008;22(10):1221-2.
18. Hall MR, Ray D, Payne JA. prevalence of hepatitis C, hepatitis B, and human immunodeficiency virus in a Grand Rapids, Michigan emergency department. J Emerg Med. 2010;38(3):401-5.
19. Shapatava E, Nelson Ke, Tsertsvadze T, Del Rio C. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug Alcohol Depend. 2006;82(Suppl 1):S35-8.